Skip to content

Hydrogen-rich Water for Molecular and Phenotypic Biomarkers of Aging

The Effects of Six-month Hydrogen-rich Water Intake on Molecular and Phenotypic Biomarkers of Aging in Men and Women Aged 70 Years and Over: a Randomized-controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04430803
Acronym
H2AGE
Enrollment
44
Registered
2020-06-12
Start date
2020-09-15
Completion date
2021-04-01
Last updated
2021-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Brief summary

This study evaluates the effects of six-month hydrogen-rich water intake on molecular and phenotypic biomarkers of aging in men and women aged 70 years and over.

Interventions

DIETARY_SUPPLEMENTHydrogen-rich water

A tablet that produces hydrogen dissolved in a glass of water

A glass of tap water

Sponsors

University of Novi Sad, Faculty of Sport and Physical Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \> 70 years * Free of acute disorders

Exclusion criteria

* History of dietary supplement use during the past 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
Change in TeloTAGGG Telomerase PCR activity in serumBaseline vs. 6 months post-interventionBaseline vs. 6 months

Secondary

MeasureTime frameDescription
Change in blood concentration of advanced glycation end productBaseline vs. 6 months post-interventionBaseline vs. 6 months
Change in lipid peroxidationBaseline vs. 6 months post-interventionBaseline vs. 6 months
Change in serum FGF21Baseline vs. 6 months post-interventionBaseline vs. 6 months
Change in DNA methylationBaseline vs. 6 months post-interventionBaseline vs. 6 months
Change in ADAS-Cog score (0-70 scale, higher scores indicating greater cognitive impairment)Baseline vs. 6 months post-interventionBaseline vs. 6 months
Change in facial wrinkling (0-100 scale; higher scores mean worse outcome)Baseline vs. 6 months post-interventionBaseline vs. 6 months
Change in maximal oxygen uptake estimated by step-in-place testBaseline vs. 6 months post-interventionBaseline vs. 6 months
Change in serum TET2Baseline vs. 6 months post-interventionBaseline vs. 6 months

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026